Prognostic value of C-reactive protein/albumin ratio in ST-segment elevation myocardial infarction

Lutfu Askin; Okan Tanriverdi; Hakan Tibilli; Serdar Turkmen

doi:10.1556/1646.11.2019.20

Prognostic value of C-reactive protein/albumin ratio in ST-segment elevation myocardial infarction

Interv Med Appl Sci. 2019 Oct 7;11(3):168-171. doi: 10.1556/1646.11.2019.20. eCollection 2020 Sep.

Authors

Lutfu Askin¹, Okan Tanriverdi¹, Hakan Tibilli¹, Serdar Turkmen¹

Affiliation

¹ Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey.

Abstract

Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.

Keywords: C-reactive protein; C-reactive protein/albumin ratio; ST-segment elevation myocardial infarction; inflammation.

Publication types

Review

Grants and funding

Funding sources: The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.